Have a look at this whitepaper prepared by our Pharmacovigilance Unit colleagues at Asphalion: Navigating Local Pharmacovigilance in European Countries, UK and Switzerland.
Local pharmacovigilance requirements across Europe can be complex, with both EU-wide legislation and country-specific obligations to consider. In this guide, our team provides a clear, country-by-country overview of key requirements for Marketing Authorisation Holders (MAHs), including local PV contact obligations, literature monitoring, and other critical activities.
Designed as a practical and visual resource, this whitepaper aims to help you better navigate the diverse regulatory landscape and support compliance across multiple jurisdictions.
To explore these topics in more detail, we invite you to read this white paper here: Whitepaper Navigating local pharmacovigilance in European Countries, UK and Switzerland
We hope you find it useful!
Contact us for more information or regulatory support: [email protected]
